Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Maria Geretti

Showing results (111-120 of 175) with videos related to

Pageof 18
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|September 26, 2009
Low-frequency K103N strengthens the impact of transmitted drug resistance on virologic responses to first-line efavirenz or nevirapine-based highly active antiretroviral therapyAnna Maria Geretti, Zoe V Fox, Clare L Booth, et al.
Antimicrobial Agents and Chemotherapy|February 12, 2020
Safety and Pharmacokinetic Characterization of Nacubactam, a Novel β-Lactamase Inhibitor, Alone and in Combination with Meropenem, in Healthy VolunteersNavita L Mallalieu, Erica Winter, Scott Fettner, et al.
The Journal of Antimicrobial Chemotherapy|September 13, 2008
Detection of low-frequency K103N mutants after unstructured discontinuation of efavirenz in the presence of the CYP2B6 516 TT polymorphismAna Garcia-Diaz, Chun Bong Lok, Chun Blok, et al.
Ebiomedicine|October 27, 2015
During Stably Suppressive Antiretroviral Therapy Integrated HIV-1 DNA Load in Peripheral Blood is Associated with the Frequency of CD8 Cells Expressing HLA-DR/DP/DQAlessandra Ruggiero, Ward De Spiegelaere, Alessandro Cozzi-Lepri, et al.
Scientific Reports|September 20, 2016
A contaminant-free assessment of Endogenous Retroviral RNA in human plasmaTimokratis Karamitros, Dimitrios Paraskevis, Angelos Hatzakis, et al.
The Journal of Antimicrobial Chemotherapy|September 2, 2015
HIV-1 RNA and HIV-1 DNA persistence during suppressive ART with PI-based or nevirapine-based regimensMaja Kiselinova, Anna Maria Geretti, Eva Malatinkova, et al.
The Journal of Antimicrobial Chemotherapy|July 31, 2020
Surveillance of HIV-1 transmitted integrase strand transfer inhibitor resistance in the UKJean L Mbisa, Juan Ledesma, Peter Kirwan, et al.
AIDS (London, England)|September 22, 2007
The ability of four genotypic interpretation systems to predict virological response to ritonavir-boosted protease inhibitorsZoe V Fox, Anna Maria Geretti, Jesper Kjaer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 8, 2014
Hepatitis B virus sub-genotype A1 infection is characterized by high replication levels and rapid emergence of drug resistance in HIV-positive adults receiving first-line antiretroviral therapy in MalawiSamir Aoudjane, Mas Chaponda, Antonio Adrián González Del Castillo, et al.
Plos One|July 23, 2013
Sensitive assessment of the virologic outcomes of stopping and restarting non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapyAnna Maria Geretti, Zoe Fox, Jeffrey A Johnson, et al.
Pageof 18

Showing results (111-120 of 175) with videos related to

Sort By:
Pageof 18
Journal of Acquired Immune Deficiency Syndromes (1999)|September 26, 2009
Low-frequency K103N strengthens the impact of transmitted drug resistance on virologic responses to first-line efavirenz or nevirapine-based highly active antiretroviral therapyAnna Maria Geretti, Zoe V Fox, Clare L Booth, et al.
Antimicrobial Agents and Chemotherapy|February 12, 2020
Safety and Pharmacokinetic Characterization of Nacubactam, a Novel β-Lactamase Inhibitor, Alone and in Combination with Meropenem, in Healthy VolunteersNavita L Mallalieu, Erica Winter, Scott Fettner, et al.
The Journal of Antimicrobial Chemotherapy|September 13, 2008
Detection of low-frequency K103N mutants after unstructured discontinuation of efavirenz in the presence of the CYP2B6 516 TT polymorphismAna Garcia-Diaz, Chun Bong Lok, Chun Blok, et al.
Ebiomedicine|October 27, 2015
During Stably Suppressive Antiretroviral Therapy Integrated HIV-1 DNA Load in Peripheral Blood is Associated with the Frequency of CD8 Cells Expressing HLA-DR/DP/DQAlessandra Ruggiero, Ward De Spiegelaere, Alessandro Cozzi-Lepri, et al.
Scientific Reports|September 20, 2016
A contaminant-free assessment of Endogenous Retroviral RNA in human plasmaTimokratis Karamitros, Dimitrios Paraskevis, Angelos Hatzakis, et al.
The Journal of Antimicrobial Chemotherapy|September 2, 2015
HIV-1 RNA and HIV-1 DNA persistence during suppressive ART with PI-based or nevirapine-based regimensMaja Kiselinova, Anna Maria Geretti, Eva Malatinkova, et al.
The Journal of Antimicrobial Chemotherapy|July 31, 2020
Surveillance of HIV-1 transmitted integrase strand transfer inhibitor resistance in the UKJean L Mbisa, Juan Ledesma, Peter Kirwan, et al.
AIDS (London, England)|September 22, 2007
The ability of four genotypic interpretation systems to predict virological response to ritonavir-boosted protease inhibitorsZoe V Fox, Anna Maria Geretti, Jesper Kjaer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 8, 2014
Hepatitis B virus sub-genotype A1 infection is characterized by high replication levels and rapid emergence of drug resistance in HIV-positive adults receiving first-line antiretroviral therapy in MalawiSamir Aoudjane, Mas Chaponda, Antonio Adrián González Del Castillo, et al.
Plos One|July 23, 2013
Sensitive assessment of the virologic outcomes of stopping and restarting non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapyAnna Maria Geretti, Zoe Fox, Jeffrey A Johnson, et al.
Pageof 18